ATH 25.0% 0.5¢ alterity therapeutics limited

Taurx is in two p3 trials that complete next year .. From what...

  1. 1,639 Posts.
    lightbulb Created with Sketch. 143
    Taurx is in two p3 trials that complete next year ..

    From what I've read, it can only get to the disease late in progression and can only help to slow progress of disease only addressing tau tangles .

    Pbt2 can potentially be effective much earlier to start chasing amyloid and can also clear tau tangles should treatment start later ... ( again my layman understanding it may be able to be used with taurx as part of a cocktail of drugs that clear and inhibit further progression however pbt2 may will prevent tau ever forming if treated early enough ) ..

    Happy to be corrected on any or all of the above

    Edit : and lets not forget there is no competitor to pbt2 from mouse study a couple of years back that showed it could reverse cognitive decline associated with ageing in a normal brain
    Last edited by m123456: 23/07/15
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
47 58163299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 57489001 48
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 28/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.